Skip to main content
GutCited

Alpha-Galactosidase para Bloating and Intestinal Gas

B

Reduces gas symptoms from high-fiber foods containing raffinose/stachyose by 50-70%. Beano (alpha-galactosidase 300 GalU) is the most studied formulation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dalpha\u002Dgalactosidase\u0026condition\u003Dbloating\u002Dand\u002Dgas'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Conclusão

Reduces gas symptoms from high-fiber foods containing raffinose/stachyose by 50-70%. Beano (alpha-galactosidase 300 GalU) is the most studied formulation.

Key Study Findings

Review
Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.
Dose: None vs: None Outcome: None Efeito: None None

População: None

Randomized Controlled Trial Double-blind
A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal …
Dose: 1200 G vs: placebo Outcome: every 30 min during 7 Efeito: None None

População: patients with ibs after three standardized

Other n=17
FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.
Dose: None vs: no treatment Outcome: None Efeito: None None

População: fabry disease but are often nonspecific

Randomized Controlled Trial n=31 2.0 weeks Double-blind
Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.
Dose: 300 GALU or 150 GALU vs: Placebo (glucose) Outcome: GI symptom severity on VAS Efeito: None pP0.006

População: IBS patients (Rome III, H2 producers)

Randomized Controlled Trial n=125 4 weeks Double-blind
Does oral α-galactosidase relieve irritable bowel symptoms?
Dose: alpha-galactosidase 600 GalU per meal vs: placebo Outcome: overall IBS symptom relief Efeito: no significant difference vs placebo >0.05

População: IBS patients

Case Reports
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha …
Dose: 3.7nmol/mL/h vs: None Outcome: None Efeito: None None

População: patients

Key Statistics

4

Estudos

300

Participantes

Positive

B

Nota

Referenced Papers

International journal of … 2021 16 citações
Scandinavian journal of … 2016 17 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
150-300 GalU (alpha-galactosidase units) per serving of gas-producing foods
standardbeanodose:
300 GalU (2-3 tablets) with first bite of problem food

Limite superior: No established upper limit; adjust per meal as needed

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Mixed --
1200 G -- Neutral --
None -- Positive 17
300 GALU or 150 GALU 2.0 weeks Positive 31
alpha-galactosidase 600 GalU per meal 4 weeks Neutral 125
3.7nmol/mL/h -- Mixed --
None 2 weeks Positive --
300 or 1200 GalU -- Positive 8

Melhor horário: With the first bite of gas-producing food

Safety & Side Effects

Efeitos Colaterais Relatados

  • Generally very well-tolerated
  • Rare allergic reactions to mold-derived enzyme (Aspergillus source)
  • May cause mild GI discomfort in rare cases

Interações Conhecidas

  • Acarbose (alpha-galactosidase may counteract the blood sugar-lowering mechanism of acarbose; contraindicated for concurrent use)
  • Miglitol (similar mechanism conflict as acarbose)

Ingestão máxima tolerável: No established upper limit; adjust per meal as needed

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Alpha-Galactosidase help with Bloating and Intestinal Gas?
Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Alpha-Galactosidase may support Bloating and Intestinal Gas management. Our evidence grade is B (Good Evidence).
How much Alpha-Galactosidase should I take for Bloating and Intestinal Gas?
Studies have used various dosages. A commonly studied range is 150-300 GalU (alpha-galactosidase units) per serving of gas-producing foods. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Alpha-Galactosidase?
Reported side effects may include Generally very well-tolerated, Rare allergic reactions to mold-derived enzyme (Aspergillus source), May cause mild GI discomfort in rare cases. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Alpha-Galactosidase and Bloating and Intestinal Gas?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.